Neuronetics Q2 Earnings Call Highlights

Key Points

• Interested successful Neuronetics, Inc.? Here are 5 stocks we similar better.

• Q2 results improved significantly: Revenue roseate 9.1% twelvemonth implicit twelvemonth to $41.6 million, portion the nett nonaccomplishment narrowed to $3.4 cardinal and adjusted EBITDA turned affirmative astatine $0.3 million.

• Greenbrook was the superior maturation driver: Clinic gross accrued 16.8% to $26.9 million, supported by supplier growth, pricing gains, amended collections and revenue-cycle improvements. Management estimates immoderate clinics person up to 40% unused capacity, creating further maturation potential.

• Neuronetics broadened NeuroStar income models and raised profitability targets: Customers tin present acquisition oregon lease systems successful summation to utilizing the accepted treatment-session model. Full-year guidance includes higher gross-margin expectations and little operating expenses, though absorption warned that second-half gross could beryllium much adaptable during the transition.

Neuronetics (NASDAQ:STIM) reported second-quarter 2026 gross growth, a sharply narrower nett nonaccomplishment and affirmative adjusted EBITDA arsenic its Greenbrook session concern expanded and the institution introduced further commercialized purchasing options for its NeuroStar transcranial magnetic stimulation, oregon TMS, systems.

Total gross roseate 9.1% twelvemonth implicit twelvemonth to $41.6 million, compared with $38.1 cardinal successful the 2nd 4th of 2025. The institution recorded a nett nonaccomplishment of $3.4 million, oregon $0.05 per share, versus a $10.1 cardinal loss, oregon $0.15 per share, a twelvemonth earlier. Adjusted EBITDA turned affirmative astatine $0.3 million, improving from antagonistic $5.6 cardinal successful the prior-year period.

Greenbrook Drives Revenue Growth

→ SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat

Greenbrook gross accrued 16.8% to $26.9 million, supported by supplier maturation and pricing improvement, Chief Financial Officer Nir Naor said. Chief Executive Officer Dan Reuvers said the session web benefited from operational enactment successful gross rhythm management, including improved diligent eligibility qualification, cleaner claims submissions, much businesslike collections and payer contracting for some TMS and SPRAVATO treatments.

Cash collections grew faster than Greenbrook gross during the quarter, according to Reuvers. The institution besides began utilizing artificial quality successful its security authorization process, which helium said helped trim operating costs.

→ Take-Two's Q1 Results Leave GTA 6 Bulls Stuck successful the Fog of War

Reuvers said occupancy remains a large accidental due to the fact that Greenbrook clinics person a mostly fixed outgo basal and inactive person disposable capacity. In effect to an expert question, helium said the institution estimates that arsenic overmuch arsenic 40% of capableness remains unconsumed astatine definite sites. Neuronetics is assessing its field-representative coverage, direct-to-consumer advertizing and peer-to-peer acquisition efforts successful an effort to amended referrals and little diligent acquisition costs.